Endocrinology

Addison’s disease, and why it should be added to every differential list, was discussed in a session at the 2024 Fetch dvm360 Conference in Kansas City

A lecture at the Fetch dvm360 Conference in Kansas City explained how stress can cause feline interstitial cystitis and explored its diagnosis and management

Dechra Limited has purchased Akston Biosciences’ developmental therapies for cats and dogs with diabetes

Felanorm is the first generic methimazole oral solution is the first generic indicated for the disease in felines, and contains the same active ingredient as Felimazole Coated Tablets.

Trupanion analyzed over 20 years’ worth of data to identify common concerns for cats

This new questionnaire was tested for validation of effectiveness in determining quality-of-life measures for this endocrine disease

Nationwide reveals the most common reason pets sought out veterinary care in 2023

An overview of this life-threatening condition will help guide veterinary practitioners

The Akston Biosciences technology is used to design therapies for humans and animals with diabetes

A recent study investigates therapeutic strategies for dogs with the disease that may also benefit humans with diabetes

We have compiled a countdown of our top 15 articles in 2023, here is number 15

A novel class of drugs normalizes blood glucose in type 2 diabetic cats by dumping sugar into urine rather than modulating glucose uptake in the tissues but patient selection and close monitoring are crucial to using them safely

A discussion on the traditional treatments for feline diabetes, with an introduction to some newer options coming to the market

Fetch Coastal lecturer Liza Wysong, BAS, RVT, VTS (CP-CF, SAIM), describes the discrepancies of this disease in dog and cat patients and the importance of an individualized approach

Fuzapladib sodium for injection can help manage clinical signs associated with the acute onset of pancreatitis, a common disorder in canine patients

The diagnostic tool tests eACTH in plasma from horses and is compatible with Zomedica’s existing in-clinic platform

This program has been approved for 0.5 hour of continuing education credit in jurisdictions that recognize RACE approval.

Appropriate patient and test selection can help to reduce misdiagnosis of hyperadrenocorticism in dogs

The Vcheck V200 in-clinic analyzer provides quantitative results in minutes

The free guidelines will help veterinary professionals diagnose and manage patients suffering from endocrine diseases

What to look for when diagnosing and managing an acute crisis

TRUFORMA’s novel technology offers reference lab performance in 20 minutes or less

Signs, risk factors, and diagnostics for when faced with this potentially fatal condition

We have compiled a countdown of our top 20 articles in 2022, here is number 13

Deb Greco, DVM, PhD, DACVIM, shares endocrinology insights and explores a diagnostic device that allows new testing options at point of care